Validfor
Healthspan
AI-native digital validation (CSV/GxP compliance) platform for pharma/biotech/medtech; $1.2M pre-seed led by DOMiNO Ventures.
Validfor builds an AI-native, agentic digital validation platform for life sciences — automating Computerized System Validation (CSV) and broader GxP compliance workflows for pharma, biotech and medical-device organisations. Traditionally validation is manual, paper-based and document-heavy; Validfor's platform manages the validation lifecycle from planning through execution and reporting, with automation and audit trails, to reduce manual validation work and make compliance scalable across regulated environments. The founding team brings decades of pharma validation, quality and digital-transformation experience, having led validation and quality initiatives at Novartis, GSK, Mundipharma and Sandoz. The company raised a $1.2M pre-seed led by DOMiNO Ventures.
Research mapping
Healthspan / Manufacture (AI) / Seed
Evidence boundary
Original analysis and independent corroboration remain under development. Commercial scale and durable technical advantage remain under review.
What makes it defensible
AI-native, agentic validation lifecycle management that automates GxP computerized-system validation, replacing manual paper-based CSV workflows.
Position in the stack: SaaS compliance layer for life-sciences manufacturing quality — automates validation documentation, review gates and audit trails.
Who buys it
Founding team
Omer Cimen — Co-founder & CEO — 20+ years in pharma/life-sciences validation, quality and digital transformation (Novartis, GSK, Mundipharma, Sandoz)
Ugur Metinol — Co-founder & COO — Pharmaceutical validation background
Aykut Ozturkmen — Co-founder — Co-founder of Validfor
SourceFinancing detail
- Last round
- Seed
Investors: DOMiNO Ventures; Curiosity VC
Mapped funds and investors
Direct relationships supported by published evidence.
Reported holdings as-of
No sourced relationships mapped yet.
Disclosed investment history
No sourced relationships mapped yet.
Showing up to four relationships in each group. ETF weights describe the fund’s portfolio, not ownership of this company. Private investment history does not establish current ownership.
Evidence & media
-
Validfor Raises 1.2M USD to Shape the Future of Life Sciences Validation with Agentic AI
What this source supports: Company press release (GlobeNewswire via NTB): $1.2M raised for agentic-AI life-sciences validation (CSV) software.
What it does not establish: No valuation, customer names, or revenue; company-issued release.
Source -
Validfor Raises $1.2 million to Shape the Future of Life Sciences Validation with Agentic AI (Curiosity VC)
What this source supports: Investor (Curiosity VC) post confirming the $1.2M round and the agentic-AI validation thesis.
What it does not establish: Investor marketing; no operating metrics or customer detail.
Source -
Validfor OU — GlobeNewswire via Ritzau
What this source supports: Nordic wire distribution of the Validfor $1.2M raise.
What it does not establish: Press-release repost; no independent reporting.
Source